peptidomimetic antibiotics target outer-membrane biogenesis pseudomonas aeruginosa
antibiotics new mechanisms action urgently required combat growing health threat posed resistant pathogenic microorganisms synthesized family peptidomimetic antibiotics based antimicrobial peptide protegrin several rounds optimization gave lead compound active nanomolar range gram-negative pseudomonas spp largely inactive gram-negative gram-positive bacteria biochemical genetic studies showed peptidomimetics non-membrane-lytic mechanism action identified homolog beta-barrel protein lptd imp/osta functions outer-membrane biogenesis cellular target peptidomimetic showed potent antimicrobial activity mouse septicemia infection model drug-resistant strains pseudomonas serious health problem family antibiotics may important therapeutic applications
